PK and PD of Albuterol Spiromax® and ProAir® Hydrofluoroalkane in Pediatric Patients With Asthma

- Asthma
- Completed

Study Title: Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Teva Identifier: ABS-AS-102

ClinicalTrials.gov Identifier: NCT01844401

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: 04/01/2013 - 10/01/2013

Phase: Phase 1

Study Type

Interventional